Efficacy and safety of pasireotide-LAR for the treatment of refractory bleeding due to gastrointestinal angiodysplasias: results of the ANGIOPAS multicenter phase II noncomparative prospective double-blinded randomized study

BACKGROUND: Gastrointestinal angiodysplasias (GIADs) could be responsible for recurrent bleeding and severe anemia. Somatostatin analogs could reduce transfusion requirements in these patients but no randomized controlled study is available. The main objective of the ANGIOPAS phase II double-blinded...

Descripción completa

Detalles Bibliográficos
Autores principales: Benamouzig, Robert, Benallaoua, Mourad, Saurin, Jean-Christophe, Boubaya, Marouane, Cellier, Christophe, Laugier, René, Vincent, Magalie, Boustière, Christian, Gincul, Rodica, Samaha, Elia, Grandval, Philippe, Aparicio, Thomas, Airinei, Gheorghe, Bejou, Bakhtiar, Bon, Cyriaque, Raynaud, Jean-Jacques, Levy, Vincent, Sautereau, Denis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818089/
https://www.ncbi.nlm.nih.gov/pubmed/29479375
http://dx.doi.org/10.1177/1756283X18756260

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818089/
https://www.ncbi.nlm.nih.gov/pubmed/29479375
http://dx.doi.org/10.1177/1756283X18756260

Ejemplares similares